Skip to content

AbbVie OÜ

Registry code (registrikood) 16094782Private limited company (Osaühing)VAT EE102315622Activity (EMTAK 82991): Muud mujal liigitamata äritegevust abistavad tegevusedActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€6.3M
▲ 25.2% vs 2024
Profit before tax (2025)
€609k
Employees, FTE (2025)
24
State taxes paid, last 4 quarters
€1.5M

Revenue, profit and employees, 2021–2025

€3.5M2021€4.3M2022€4.3M2023€5.0M2024€6.3M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2021€3,541,380€334,462€335,088-€1,741,32516
2022€4,299,839€399,152€404,082€962,75717
2023€4,297,159€422,479€454,414€1,417,17119
2024€5,013,358€509,204€557,944€1,975,11520
2025€6,275,151€567,658€608,531€2,583,64624

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2021€0€1,088,430€2,829,755—-€1,741,325
2022—€1,559,302€596,545—€962,757
2023—€2,117,771€700,600—€1,417,171
2024—€2,826,535€851,420—€1,975,115
2025—€3,677,566€1,093,920—€2,583,646

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€210,689€189,239€847,08929
2022 Q2€227,910€220,928€943,48946
2022 Q3€205,208€194,399€905,91328
2022 Q4€217,981€193,617€1,447,76654
2023 Q1€178,232€167,704€1,279,19224
2023 Q2€232,399€216,056€892,88243
2023 Q3€190,115€181,150€947,83626
2023 Q4€187,569€177,138€1,050,88365
2024 Q1€214,917€204,624€1,429,90623
2024 Q2€256,366€243,118€933,80349
2024 Q3€237,617€222,999€1,172,78229
2024 Q4€226,654€213,978€1,617,97855
2025 Q1€280,789€248,151€1,975,68231
2025 Q2€395,454€375,090€1,324,91967
2025 Q3€345,561€332,258€1,553,66632
2025 Q4€278,578€266,396€1,870,87168
2026 Q1€392,965€365,831€2,165,77736
2026 Q2€439,895€418,453€1,431,89170
2026 Q3€389,489€371,951€1,787,92446

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), AbbVie OÜ reported revenue of €6,275,151.

The company closed the 2025 financial year with a net profit of €608,531.

Revenue increased by 25.2% from €5,013,358 in 2024 to €6,275,151 in 2025.

Revenue grew at a compound annual rate of 15.4% between 2021 and 2025.

Equity accounted for 70.3% of total assets of €3,677,566 at the end of the 2025 reporting period.

With 24 full-time-equivalent employees in 2025, revenue per employee was €261,465.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, AbbVie OÜ reported €7,256,463 in turnover.

EMTA recorded 46 employees for the quarter ending Q3 2026, compared with 24 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.